Interleukin-10 production during septicaemia
- 19 March 1994
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 343 (8899), 707-708
- https://doi.org/10.1016/s0140-6736(94)91584-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Interleukin‐10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharideEuropean Journal of Immunology, 1993
- Modified Immunological Status of Anti-IL-10 Treated MiceCellular Immunology, 1993
- Interleukin 10 protects mice from lethal endotoxemia.The Journal of Experimental Medicine, 1993
- In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A.The Journal of Experimental Medicine, 1993
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Septic shock: pathogenesisThe Lancet, 1991